FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy (Q36884429)
Jump to navigation
Jump to search
scientific article published on 16 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy |
scientific article published on 16 March 2016 |
Statements
1 reference
FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy (English)
1 reference
Dickran Kazandjian
1 reference
Daniel L Suzman
1 reference
Gideon Blumenthal
1 reference
Sirisha Mushti
1 reference
Kun He
1 reference
Meredith Libeg
1 reference
Patricia Keegan
1 reference
Richard Pazdur
1 reference
16 March 2016
1 reference
1 reference
634-642
1 reference
Identifiers
1 reference
1 reference
1 reference